Engineered Human Heavy-Chain Ferritin with Half-Life Extension and Tumor Targeting by PAS and RGDK Peptide Functionalization
Ferritin, one of the most investigated protein nanocages, is considered as a promising drug carrier because of its advantageous stability and safety. However, its short half-life and undesirable tumor targeting ability has limited its usage in tumor treatment. In this work, two types of functional p...
Saved in:
Main Authors: | Shuang Yin (Author), Yan Wang (Author), Bingyang Zhang (Author), Yiran Qu (Author), Yongdong Liu (Author), Sheng Dai (Author), Yao Zhang (Author), Yingli Wang (Author), Jingxiu Bi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impacts of myosin heavy chain phenotypes on recovery of leg extension force after ACL-reconstructed knee
by: Tetsuo Kobayashi, et al.
Published: (2023) -
Enhanced Cellular Uptake of H-Chain Human Ferritin Containing Gold Nanoparticles
by: Italo Moglia, et al.
Published: (2021) -
Characterization of neutralizing chimeric heavy-chain antibodies against tetanus toxin
by: Kexuan Cheng, et al.
Published: (2024) -
Ultrasound Assessment of Placenta Accreta Spectrum (PAS), Clinical Management of PAS in Our Society IS-PAS: Minutes of 2020 Online International Workshop on PAS
by: Frederic Chantraine, et al.
Published: (2021) -
La perspective transactionnelle de l'occupation racontée pas à pas
by: Isabel Margot-Cattin
Published: (2018)